These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3545723)

  • 1. Immunogenicity of biosynthetic human insulin. Humoral immune response in diabetic patients beginning insulin treatment and in patients previously treated with other insulins.
    Di Mario U; Arduini P; Tiberti C; Lombardi G; Pietravalle P; Andreani D
    Diabetes Res Clin Pract; 1986; 2(6):317-24. PubMed ID: 3545723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer from purified porcine insulins to semisynthetic human insulins decreases insulin antibodies and circulating immune complexes in diabetic children and adolescents. A two-year follow-up.
    Dorchy H; Duchateau J; Bosson D; D'Hooge D
    Diabete Metab; 1989; 15(3):107-10. PubMed ID: 2668052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human cellular immune response to insulin: a study in unexposed control subjects and type I diabetic patients on acute and chronic treatment.
    Richens ER; Seward ME; Luqman WA; Hartog M
    Acta Diabetol Lat; 1986; 23(4):309-22. PubMed ID: 3551427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of monocomponent human and porcine insulin in newly diagnosed type 1 (insulin-dependent) diabetic children.
    Heding LG; Marshall MO; Persson B; Dahlquist G; Thalme B; Lindgren F; Akerblom HK; Rilva A; Knip M; Ludvigsson J
    Diabetologia; 1984 Jul; 27 Suppl():96-8. PubMed ID: 6383927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals.
    Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E
    Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A twelve month double-blind randomized study of the efficacy and immunogenicity of human and porcine insulins in non-insulin-dependent diabetics.
    HO LT; Lam HC; Wu MS; Kwok CF; Jap TS; Tang KT; Wang LM; Liu YF
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 May; 47(5):313-9. PubMed ID: 1649672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of semisynthetic human insulin in man. Long-term comparison with porcine monocomponent insulin.
    Luyckx AS; Daubresse JC; Jaminet C; Scheen A; Lefebvre PJ
    Acta Diabetol Lat; 1986; 23(2):101-6. PubMed ID: 3529776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in insulin antibodies 42 months after transfer from porcine to human monocomponent insulins.
    Virgili F; Frigato F; Magnanini PG; Coronel GA; Iavicoli M
    Diabetes Res; 1988 Sep; 9(1):19-20. PubMed ID: 3071441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin.
    Fineberg NS; Fineberg SE; Anderson JH; Birkett MA; Gibson RG; Hufferd S
    Diabetes; 1996 Dec; 45(12):1750-4. PubMed ID: 8922361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of IgE antibodies to human (recombinant DNA), porcine, and bovine insulins in diabetic subjects.
    Fireman P; Fineberg SE; Galloway JA
    Diabetes Care; 1982; 5 Suppl 2():119-25. PubMed ID: 6765521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HLA typing and insulin antibody production in insulin-dependent diabetics].
    Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
    Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular immune alterations associated with human insulin therapy.
    Eichner HL; Lauritano AA; Woertz LL; Selam JL; Gupta S; Charles MA
    Diabetes Res; 1988 Jul; 8(3):111-5. PubMed ID: 3067952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of monocomponent human and porcine insulin in non-insulin dependent diabetes mellitus.
    Lam HC; Tang KT; Wang JT; Liu YF; Wang LM; Ho LT
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Mar; 41(3):217-22. PubMed ID: 3052740
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experiences with monocomponent insulins].
    Bruni Bocher K; Giolitti A; Turco GL; Benedetto P; Bruni B
    Minerva Med; 1975 Mar; 66(19):909-30. PubMed ID: 1124144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and immunogenicity of human and monocomponent porcine insulin: a randomized double-blind study in diabetic patients previously treated with insulin.
    Storms GE; Lutterman JA; van 't Laar A
    Neth J Med; 1986; 29(10):296-302. PubMed ID: 3540688
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of insulin antibodies, metabolic control and B-cell function in newly diagnosed insulin dependent diabetic children treated with monocomponent human insulin or monocomponent porcine insulin.
    Marshall MO; Heding LG; Villumsen J; Akerblom HK; Baevre H; Dahlquist G; Kjaergaard JJ; Knip M; Lindgren F; Ludvigsson J
    Diabetes Res; 1988 Dec; 9(4):169-75. PubMed ID: 3073903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of highly purified porcine and human insulins in diabetic patients with high titers of insulin antibody.
    Lam HC; Ho LT; Tang KT; Wang LM; Kwok CF; Liu YF; Hsiao LJ; Li SH
    Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):346-51. PubMed ID: 2677227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical examination of diabetic patients treated with monocomponent insulin manufactured by MP Polfa].
    Orłowska-Kunikowska E; Horoszek-Maziarz S; Loss-Fisior R; Semetkowska-Jurkiewicz E; Dominiak K; Wójcikowski C
    Pol Tyg Lek; 1989 May 22-29; 44(21-22):503-6. PubMed ID: 2702341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin antibodies in the serum of diabetic children treated from the diagnosis of the disease with highly purified insulins.
    Akerblom HK; Mäkelä AL
    Acta Paediatr Scand Suppl; 1977; (270):69-79. PubMed ID: 98959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monocomponent insulins in the treatment of juvenile diabetes].
    Kopecký A; Vavrinec J; Kimlová I; Pospísilová D
    Cesk Pediatr; 1984 Apr; 39(4):223-5. PubMed ID: 6375877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.